Volume 87 Issue 32 | p. 19 | Concentrates
Issue Date: August 10, 2009

Cleveland Clinic Invests In Small Firm

Department: Business
Keywords: FTA Therapeutics, PURE Bioscience, antimicrobials

Cleveland Clinic, a leading academic medical center, has taken an equity stake in FTA Therapeutics, a Pennsylvania-based developer of antimicrobials, in return for conducting clinical studies with FTA. The studies will be part of a project between FTA and biotech firm Pure Bioscience focused on a silver dihydrogen citrate (SDC) antimicrobial. FTA is completing preclinical work on SDC formulations to prepare for trials on wound care and acne later this year.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment